NASDAQ:EIGR
Eiger BioPharmaceuticals, Inc. Stock News
$1.73
+0 (+0%)
At Close: Apr 26, 2024
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:27am, Wednesday, 17'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xenetic Biosciences
Aquestive Therapeutics (AQST) Receives a Buy from Wedbush - Markets
12:16pm, Sunday, 14'th Jun 2020
In a report issued on June 12, Liana Moussatos from Wedbush maintained a Buy rating on Aquestive Therapeutics (AQST –
Hedge Funds Can’t Buy Enough Of Eiger BioPharmaceuticals, Inc. (EIGR)
05:22pm, Monday, 08'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020
08:05pm, Friday, 29'th May 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and
The
Eiger to Present at Jefferies Virtual Healthcare Conference 2020
08:05pm, Tuesday, 26'th May 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management wil
May 25, 2020 (CDN Newswire via Comtex) --
Global Dilated Cardiomyopathy Therapeutic Market 2020 by Company, Regions, Type and Application, Forecast to 2026...
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:12pm, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) * ADC Therapeutics SA (NYSE: ADCT) (IPOed May 15) * A
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and Dr
Is Eiger BioPharmaceuticals (EIGR) Stock a Solid Choice Right Now?
12:57pm, Friday, 15'th May 2020
Eiger BioPharmaceuticals (EIGR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
12:00pm, Thursday, 30'th Apr 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the first patients h
Eiger Biopharmaceuticals (EIGR) Gets a Buy Rating from Wedbush
01:25pm, Tuesday, 28'th Apr 2020
Wedbush analyst Liana Moussatos maintained a Buy rating on Eiger Biopharmaceuticals (EIGR – Research Report) today and set a price
Bank of New York Mellon Corp Purchases 1,926 Shares of Eiger Biopharmaceuticals Inc (NASDAQ:EIGR)
08:18am, Saturday, 25'th Apr 2020
Bank of New York Mellon Corp grew its position in shares of Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) by 2.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities
Will Eiger BioPharmaceuticals Continue to Surge Higher?
02:05pm, Wednesday, 22'nd Apr 2020
As of late, it has definitely been a great time to be an investor Eiger BioPharmaceuticals
Clinical trials in the age of COVID: Shelter-in-place, hospital restrictions cause drug study delays
10:08pm, Thursday, 09'th Apr 2020
Sean McCarthy, president and CEO of CytomX Therapeutics Inc.
